ArticlebioRxiv : the preprint server for biology2026
Preclinical validation of AAV9-TECPR2 gene therapy in a novel knock-in model of TECPR2-related disorder.
Bruna Lenfers Turnes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.